Niccolò Lenci

Niccolò Lenci
Policlinico Universitario Agostino Gemelli, Rome, Italy

About

11
Publications
297
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
25
Citations
Citations since 2017
10 Research Items
25 Citations
20172018201920202021202220230246810
20172018201920202021202220230246810
20172018201920202021202220230246810
20172018201920202021202220230246810

Publications

Publications (11)
Article
Full-text available
Background: One of the greatest challenges in semi-rigid ureteroscopies, for both stones and tumors, is the control of endoscopic vision and the maintenance of low intracavitary liquid pressure. We present a comparison between two operative techniques: in the first method an ordinary guide wire (diameter 0.032'') is used for the procedure; in the...
Article
Full-text available
Biopsy proven Gleason score is essential to decide treatment modalities for prostate cancer, either surgical (radical prostatectomy) or non-surgical (active surveillance, watchful waiting, radiation therapy and hormone therapy). Several studies indicated that biopsy proven Gleason score may underestimate Gleason score at radical prostatectomy, henc...
Article
Full-text available
Metanephric adenoma (MA) is an uncommon benign renal tumor whose histomorphological aspect resembles that of Wilms' tumor and papillary renal cell carcinoma. From a diagnostic and therapeutic perspective, recognition of this entity is important as it has a more favorable clinical outcome compared with Wilms' tumor and papillary renal cell carcinoma...
Article
Full-text available
Background: Bladder leiomyosarcoma is the most frequent mesenchymal neoplasm of the bladder. However, the rarity of the disease and some morphological aspects could give serious problems to differential diagnosis. Case presentation: A 86-year-old male patient was referred to our institution to undergo endoscopic low-urinary-tract re-evaluation 2...
Article
Mitomycin C (MMC) as an intravesical chemotherapeutic agent is a well-known option for treatment of nonmuscle invasive bladder cancer (NMIBC) recurrence; it is probably the most commonly used agent given its low rate of side effects and its efficacy. Both the American Urologic Association (AUA) and European Association of Urology (EAU) consider MMC...

Network

Cited By